Gastrointestinal well-being in subjects reporting mild gastrointestinal discomfort: Characteristics and properties of a global assessment measure

British Journal of Nutrition

Volumn 110, Issue 7, 2013, Pages 1263-1271

  Guyonnet, Denis ^a   Naliboff, Bruce ^b   Rondeau, Pascale ^a   Mayer, Emeran ^b   Chassany, Olivier ^c  

^a DANONE RESEARCH   (France)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

Gastrointestinal well being; Overall assessment; Patient reported outcomes

Indexed keywords

PROBIOTIC AGENT;

ABDOMINAL PAIN; ADULT; ARTICLE; BLOATING; BORBORYGMUS; CONSTRUCT VALIDITY; CONTROLLED STUDY; DAIRY PRODUCT; DEFECATION HABIT; DIGESTIVE FUNCTION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; FECES ANALYSIS; FEMALE; FERMENTED PRODUCT; FLATULENCE; FOOD INTAKE; GASTROINTESTINAL SYMPTOM; HUMAN; HUMAN EXPERIMENT; MILK; NONHUMAN; NORMAL HUMAN; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; WELLBEING;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; DAIRY PRODUCTS; DOUBLE-BLIND METHOD; FEMALE; GASTROINTESTINAL DISEASES; GASTROINTESTINAL TRACT; HEALTH; HUMANS; MIDDLE AGED; PAIN; PATIENT SATISFACTION; PROBIOTICS; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84884613211     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114513000275     Document Type: Article

References (22)

1. EFSA on Dietetic Products, Nutrition and Allergies (NDA) (2011) Guidance on the scientific requirements for health claims related to gut and immune function. EFSA J 9, 1984
2. Clarke G, Cryan JF, Dinan TG, et al. (2012) Review article: probiotics for the treatment of irritable bowel syndrome - focus on lactic acid bacteria. Aliment Pharmacol Ther 35, 403-413
3. Whelan K (2011) Probiotics and prebiotics in the management of irritable bowel syndrome: a review of recent clinical trials and systematic reviews. Curr Opin Clin Nutr Metab Care 14, 581-587
4. Moayyedi P, Ford AC, Talley NJ, et al. (2010) The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review. Gut 59, 325-332
5. Longstreth GF, Thompson WG, Chey WD, et al. (2006) Functional bowel disorders. Gastroenterology 130, 1480-1491
6. van Kerkhoven LA, Eikendal T, Laheij RJ, et al. (2008) Gastrointestinal symptoms are still common in a general Western population. Neth J Med 66, 18-22
7. Leibbrand R, Cuntz U & Hiller W (2002) Assessment of functional gastrointestinal disorders using the Gastro- Questionnaire. Int J Behav Med 9, 155-172
8. Frexinos J, Denis P, Allemand H, et al. (1998) Descriptive study of functional digestive symptoms in the French general population. Gastroenterol Clin Biol 22, 785-791
9. Talley NJ, Boyce P & Jones M (1998) Identification of distinct upper and lower gastrointestinal symptom groupings in an urban population. Gut 42, 690-695
10. Heaton KW, ODonnell LJD, Braddon FE, et al. (1992) Symptoms of irritable bowel syndrome in a British urban community: consulters and nonconsulters. Gastroenterology 102, 1962-1967
11. Trentacosti AM, He R, Burke LB, et al. (2010) Evolution of clinical trials for irritable bowel syndrome: issues in end points and study design. Am J Gastroenterol 105, 731-735
12. Guyonnet D, Schlumberger A, Mhamdi L, et al. (2009) Fermented milk containing Bifidobacterium lactis DN-173010 improves gastrointestinal well-being and digestive symptoms in a global population of women. A randomised, doubleblind, parallel, controlled study. Br J Nutr 102, 1654-1662
13. Guyatt GH, Deyo RA, Charlson M, et al. (1989) Responsiveness and validity in health status measurement: a clarification. J Clin Epidemiol 42, 403-408
14. Irvine EJ, Whitehead WE, Chey WD, et al. (2006) Design of treatment trials for functional gastrointestinal disorders. Gastroenterology 130, 1538-1551
15. US Food and Drug Administration (2010) Guidance for industry irritable bowel syndrome - clinical evaluation of products for treatment http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ default.htm
16. ODonnell LJD, Virjee J & Heaton KW (1990) Detection of pseudodiarrhoea by simple clinical assessment of intestinal transit rate. Br Med J 300, 439-440
17. Guyonnet D, Chassany O, Picard C, et al. (2008) Perceived subject outcomes and impact on health-related quality of life associated with diet using the new Food Benefits Assessment (FBA) questionnaire: development and psychometric validation. Public Health Nutr 11, 1163-1172
18. Dupuy HJ (1984) The psychological general well-being (PGWB) index. In Assessment of Quality of Life in Clinical Trials of Cardiovascular Therapies, chapter 9, pp 170-184 [NK Wenger, ME Mattson, CF Furberg and J Elinson, editors] New York: Le Jacq Publishing
19. Chang L & Drossman DA (2010) Rome Foundation Endpoints and Outcomes Conference 2009: optimizing clinical trials in FGID. Am J Gastroenterol 105, 722-730
20. Passos MC, Lembo AJ, Conboy LA, et al. (2009) Adequate relief in a treatment trial with IBS patients: a prospective assessment. Am J Gastroenterol 104, 912-919
21. EFSA Scientific Committee (2011) Statistical significance and biological relevance. EFSA J 9, 2372
22. Withehead WE, Palsson OS, Levy RL, et al. (2006) Reports of satisfactory relief by IBS patients receiving usual medical care are confounded by baseline symptom severity and do not accurately reflect symptom improvement. Am J Gastroenterol 101, 1057-1065